OBJECTIVE: Hippocampal volume decrease associated with illness burden is among the most replicated findings in unipolar depression. The absence of hippocampal volume changes in most studies of individuals with bipolar disorder (BD) may reflect neuroprotective effects of lithium (Li). METHODS: We recruited 17 BD patients from specialized Li clinics, with at least two years of regularly monitored Li treatment (Li group), and compared them to 12 BD participants with < 3 months of lifetime Li exposure and no Li treatment within two years prior to the scanning (non-Li group) and 11 healthy controls. All BD patients had at least 10 years of illness and five episodes. We also recruited 13 Li-naïve, young BD participants (15-30 years of age) and 18 sex- and age-matched healthy controls. We compared hippocampal volumes obtained from 1.5-T magnetic resonance imaging (MRI) scans using optimized voxel-based morphometry with small volume correction. RESULTS: The non-Li group had smaller left hippocampal volumes than controls (corrected p < 0.05), with a trend for lower volumes than the Li group (corrected p < 0.1), which did not differ from controls. Young, Li-naïve BD patients close to the typical age of onset had comparable hippocampal volumes to controls. CONCLUSIONS: Whereas patients with limited lifetime Li exposure had significantly lower hippocampal volumes than controls, patients with comparable illness burden, but with over two years of Li treatment, or young Li-naïve BD patients, showed hippocampal volumes comparable to controls. These results provide indirect support for neuroprotective effects of Li and negative effects of illness burden on hippocampal volumes in bipolar disorders.
OBJECTIVE: Hippocampal volume decrease associated with illness burden is among the most replicated findings in unipolar depression. The absence of hippocampal volume changes in most studies of individuals with bipolar disorder (BD) may reflect neuroprotective effects of lithium (Li). METHODS: We recruited 17 BD patients from specialized Li clinics, with at least two years of regularly monitored Li treatment (Li group), and compared them to 12 BD participants with < 3 months of lifetime Li exposure and no Li treatment within two years prior to the scanning (non-Li group) and 11 healthy controls. All BD patients had at least 10 years of illness and five episodes. We also recruited 13 Li-naïve, young BD participants (15-30 years of age) and 18 sex- and age-matched healthy controls. We compared hippocampal volumes obtained from 1.5-T magnetic resonance imaging (MRI) scans using optimized voxel-based morphometry with small volume correction. RESULTS: The non-Li group had smaller left hippocampal volumes than controls (corrected p < 0.05), with a trend for lower volumes than the Li group (corrected p < 0.1), which did not differ from controls. Young, Li-naïve BD patients close to the typical age of onset had comparable hippocampal volumes to controls. CONCLUSIONS: Whereas patients with limited lifetime Li exposure had significantly lower hippocampal volumes than controls, patients with comparable illness burden, but with over two years of Li treatment, or young Li-naïve BD patients, showed hippocampal volumes comparable to controls. These results provide indirect support for neuroprotective effects of Li and negative effects of illness burden on hippocampal volumes in bipolar disorders.
Authors: Stephen M Smith; Mark Jenkinson; Mark W Woolrich; Christian F Beckmann; Timothy E J Behrens; Heidi Johansen-Berg; Peter R Bannister; Marilena De Luca; Ivana Drobnjak; David E Flitney; Rami K Niazy; James Saunders; John Vickers; Yongyue Zhang; Nicola De Stefano; J Michael Brady; Paul M Matthews Journal: Neuroimage Date: 2004 Impact factor: 6.556
Authors: Stephen M Strakowski; Melissa P DelBello; Molly E Zimmerman; Glen E Getz; Neil P Mills; Jennifer Ret; Paula Shear; Caleb M Adler Journal: Am J Psychiatry Date: 2002-11 Impact factor: 18.112
Authors: A J Rush; D E Giles; M A Schlesser; P J Orsulak; J E Weissenburger; C L Fulton; C J Fairchild; H P Roffwarg Journal: Biol Psychiatry Date: 1997-05-01 Impact factor: 13.382
Authors: Hilary P Blumberg; Joan Kaufman; Andres Martin; Ronald Whiteman; Jane Hongyuan Zhang; John C Gore; Dennis S Charney; John H Krystal; Bradley S Peterson Journal: Arch Gen Psychiatry Date: 2003-12
Authors: Glenda M MacQueen; Stephanie Campbell; Bruce S McEwen; Kathryn Macdonald; Shigeko Amano; Russell T Joffe; Claude Nahmias; L Trevor Young Journal: Proc Natl Acad Sci U S A Date: 2003-01-24 Impact factor: 11.205
Authors: Paolo Brambilla; Keith Harenski; Mark Nicoletti; Roberto B Sassi; Alan G Mallinger; Ellen Frank; David J Kupfer; Matcheri S Keshavan; Jair C Soares Journal: J Psychiatr Res Date: 2003 Jul-Aug Impact factor: 4.791
Authors: Barbara K Chen; Roberto Sassi; David Axelson; John P Hatch; Marsal Sanches; Mark Nicoletti; Paolo Brambilla; Matcheri S Keshavan; Neal D Ryan; Boris Birmaher; Jair C Soares Journal: Biol Psychiatry Date: 2004-09-15 Impact factor: 13.382
Authors: Robert M Post; Kirk D Denicoff; Gabriele S Leverich; Lori L Altshuler; Mark A Frye; Trisha M Suppes; A John Rush; Paul E Keck; Susan L McElroy; David A Luckenbaugh; Chad Pollio; Ralph Kupka; Willem A Nolen Journal: J Clin Psychiatry Date: 2003-06 Impact factor: 4.384
Authors: S Kittel-Schneider; T Wobrock; H Scherk; T Schneider-Axmann; S Trost; D Zilles; C Wolf; A Schmitt; B Malchow; A Hasan; M Backens; W Reith; P Falkai; O Gruber; A Reif Journal: Eur Arch Psychiatry Clin Neurosci Date: 2014-06-24 Impact factor: 5.270
Authors: C I Giakoumatos; P Nanda; I T Mathew; N Tandon; J Shah; J R Bishop; B A Clementz; G D Pearlson; J A Sweeney; C A Tamminga; M S Keshavan Journal: J Psychiatr Res Date: 2014-12-23 Impact factor: 4.791
Authors: Martha Sajatovic; Sergio A Strejilevich; Ariel G Gildengers; Annemiek Dols; Rayan K Al Jurdi; Brent P Forester; Lars Vedel Kessing; John Beyer; Facundo Manes; Soham Rej; Adriane R Rosa; Sigfried Ntm Schouws; Shang-Ying Tsai; Robert C Young; Kenneth I Shulman Journal: Bipolar Disord Date: 2015-09-19 Impact factor: 6.744